Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Altis Labs has unveiled Nota, a groundbreaking clinical information platform designed to expedite therapeutic research and development. By harnessing the power of AI, Nota can forecast patient outcomes based on imaging data, allowing sponsors to efficiently prioritize their most promising therapies. This innovative platform empowers researchers to effectively utilize clinical trial imaging data, gain access to predictive imaging biomarkers, and enhance R&D efforts on a larger scale. With Altis’ cloud-based software, which employs advanced deep learning techniques, biopharma companies can integrate detailed outcome predictions at the image, patient, and cohort levels, ultimately refining clinical trial design and boosting confidence in anticipating clinical endpoints. The insights generated by Nota have the potential to drastically shorten development timelines, reduce drug development expenses, and increase the chances of success across various therapeutic areas, paving the way for a new era in clinical research. As the demand for efficient drug development continues to rise, Nota stands out as a vital tool for the biopharmaceutical industry.
Description
A customer initiates a new account application through various channels, such as in-person at the branch, online, via mobile apps, or through the contact center. Early Warning assesses the probability that the customer is genuine by utilizing our top-notch banking data. This allows for real-time evaluation of identity validity, enhancing the detection of synthetic and altered identities. Additionally, Early Warning forecasts the likelihood that a customer may experience default due to first-party fraud within the initial nine months after opening an account. By applying predictive intelligence, we gain deeper insights into customer behavior. The system also estimates the risk of default stemming from account mismanagement during the same timeframe. Based on these assessments, applicant privileges can be customized to match your institution's risk tolerance. Harnessing real-time predictive analytics facilitates more informed decision-making. This approach not only broadens access for more customers to the conventional financial system but also helps manage risk levels, which could lead to an increase in potential revenue. Ultimately, balancing risk management with customer inclusion is key to fostering a healthier financial ecosystem.
API Access
Has API
No
API Access
Has API
No
Integrations
NuDetect
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
No
Webinars
No
Live Training (Online)
No
In Person
No
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
No
In Person
No
Vendor Details
Company Name
Altis Labs
Founded
2019
Country
Canada
Website
www.altislabs.com/news/altis-labs-announces-launch-of-nota-a-clinical-information-platform-to-accelerate-therapeutic-r-d
Vendor Details
Company Name
Early Warning
Founded
1990
Country
United States
Website
www.earlywarning.com/products/identity-chek-service-new-account-scores